Cite
HARVARD Citation
Demols, A. et al. (n.d.). O-003Exploratory analysis based on tumor location of REACHIN, a randomized, double-blinded, placebo-controlled phase 2 trial of regorafenib after failure of gemcitabine and platinum-based chemotherapy for advanced/metastatic biliary tract tumors. Annals of oncology. p. . [Online].